Secondary endpoints were changes in lipids other than total cholesterol , insulin sensitivity , total bilirubin , estimated glomerular filtration rate , and CD4 and CD8 cell counts , and the proportion of patients with plasma HIV RNA < 50 HIV-1 RNA copies/mL and study drug discontinuation because of adverse effects at 24 weeks .